← Browse by Condition
Medical Condition
glioblastoma multiforme
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1, Phase 3
NCT06356883 Phase 2
Recruiting
Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
Enrollment
120 pts
Location
Canada
Sponsor
Université de Sherbrooke
NCT03911388 Phase 1
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06496971 Phase 3
Recruiting
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Enrollment
32 pts
Location
Taiwan
Sponsor
NaviFUS Corporation
NCT06011109 Phase 1, Phase 2
Recruiting
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
Enrollment
30 pts
Location
United States
Sponsor
Aveta Biomics, Inc.